These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2567104)

  • 1. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetanic fade following administration of nondepolarizing neuromuscular blocking drugs.
    Gibson FM; Mirakhur RK
    Anesth Analg; 1989 Jun; 68(6):759-62. PubMed ID: 2567584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic facilitatory adenosine A2A receptors mediate fade induced by neuromuscular relaxants that exhibit anticholinesterase activity.
    Bornia EC; Correia-de-Sá P; Alves-Do-Prado W
    Clin Exp Pharmacol Physiol; 2011 Mar; 38(3):164-9. PubMed ID: 21208254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between block-of-twitch and train-of-four fade in the mouse phrenic nerve-diaphragm preparation.
    Storella RJ; Slomowitz SA; Rosenberg H
    Can J Anaesth; 1991 Apr; 38(3):401-7. PubMed ID: 1674678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the train-of-four fade profiles produced by vecuronium and atracurium.
    Fletcher JE; Sebel PS; Mick SA; Van Duys J; Ryan K
    Br J Anaesth; 1992 Feb; 68(2):207-8. PubMed ID: 1347231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine potentiates nondepolarizing neuromuscular relaxants in a primate.
    Tsai SK; Lee C
    Anesth Analg; 1989 Jan; 68(1):5-8. PubMed ID: 2562910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Onset and duration of action times for the new muscle relaxants vecuronium and atracurium. Comparison with pancuronium].
    Melloni C; Fusari M; Ortelli L; Cataldi F; Pasini L
    Minerva Anestesiol; 1988 Jun; 54(6):233-48. PubMed ID: 2907778
    [No Abstract]   [Full Text] [Related]  

  • 10. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting train-of-four fade.
    Pearce AC; Casson WR; Jones RM
    Br J Anaesth; 1985 Jun; 57(6):602-6. PubMed ID: 2860913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of d-tubocurarine, pancuronium and atracurium on the responses of gastrocnemius and soleus muscles in the cat.
    Choi WW; Gergis SD; Sokoll MD
    Acta Anaesthesiol Scand; 1984 Dec; 28(6):608-11. PubMed ID: 6549246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium.
    Bevan DR; Smith CE; Donati F
    Anesthesiology; 1988 Aug; 69(2):272-6. PubMed ID: 2900612
    [No Abstract]   [Full Text] [Related]  

  • 17. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
    Mehta MP; Sokoll MD; Gergis SD
    Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fade characteristics and onset times following administration of pancuronium, tubocurarine and a mixture of both agents.
    Cashman JN; Jones RM; Vella LM
    Br J Anaesth; 1985 May; 57(5):488-92. PubMed ID: 3994882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.